Pharmaceutical excipients market worth 7 356 2 million

Company Snapshot Figure 42 Kerry: Specialty excipient blends can add value to pharmaceutical products by differentiating them from competitive products, and by optimizing the production process.

The large share can be attributed to the increased use of fillers and diluents in the development and production of solid oral drugs.

Pharmaceutical Excipients Market to Surpass US$ 8 Billion by 2024

By product, the organic chemical excipients segment accounted for the largest share of the market On the basis of products, the organic chemical excipients segment accounted for the largest share of the pharmaceutical excipients market, in Quality by design is a scientific method that involves risk-based approach at product concept stage.

In addition, manufacture of oral liquid formulations is gaining popularity as a patient-centric drug delivery format, despite having shortcomings such as shorter shelf life and need for airtight packaging. This regional segment shows significant market growth opportunities owing to the presence of well-established pharmaceutical companies such as Novartis and Roche, whose large production capacities lead to high quantity excipient consumption.

Europe dominated the market in Europe accounted for the largest share of the Pharmaceutical Excipients Market infollowed by North America. The growing demand for plant products are projected to favor the market for pharmaceutical excipients market in the near future The global pharmaceutical excipients market is characterized by strategic research and development and advancements in the excipients processing, also the organizations involved in the manufacturing of the excipients are now inclined towards product development to expand their product portfolio.

Company Snapshot Figure 47 Lubrizol: Company Snapshot Figure 44 Croda: Though there are various types of pharmaceutical excipients, only particular excipients are most compatible for a specific dosage form.

Your Shopping Cart Is Empty

Solvents are also projected to benefit from increased shipments of parenteral drugs, although gains in dollar terms will be limited by the continued decline in glycerin prices due to oversupply. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Shipments of oral pharmaceuticals are forecast to rise at a faster pace than seen in the period, supporting accelerated gains in demand for fillers, binders, coatings, flavoring agents, capsules, and disintegrants.

It also discusses the key market drivers, restraints, and opportunities of this market and its sub-markets. They offer advantages such as increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst Custom Market Research Services We will customize the research for you, in case the report listed above does not meet with your exact requirements.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

However, the increasing cost of raw materials, stringent regulatory requirements and quality specifications, and the increasingly competitive environment are factors that inhibit the growth of the market to a certain extent.

Pharmaceutical Excipients Market worth $7,352 Million by 2018

The pharmaceutical excipients market has experienced extensive growth in the past few years, mainly attributed to the various advancements in the pharmaceutical industry related to drug delivery technologies. The rise in market for oral formulation is expected to favor the market for pharmaceutical excipients over the forecast period.

Market Snapshot Figure 32 Asia Pacific: Pharmaceutical excipients possess various properties that are utilized by API for making bulk of any product and can also improve drugs bioavailability in certain cases.

Global Pharmaceutical Excipients Market: This is expected to grow in the near future on the backdrop of rise in demand for oral dosage forms globally.

Pharmaceutical Excipients Market Worth 53 Billion USD by 2023

The parenteral formulations segment is expected to grow at the highest CAGR owing to the increasing incidence of infectious diseases, such as hepatitis, tuberculosis, cardiovascular diseases, diabetes, and cancer, where parenteral formulations are used as a major line of treatment.

InEurope accounted for the largest share of this market. For instance, according to pharmaceutical technology, inAshland announced the expansion of production of Polyplasdone cross-linked polyvinylpyrrolidone PVPP in Texas City manufacturing facility.

Pharmaceutical Excipients Market worth 53 Billion USD by 2023

The report analyzes the market by product, functionality, type of formulation, and region.On the basis of products, the organic chemical excipients segment accounted for the largest share of the Pharmaceutical Excipients Market, in This can be attributed to the use of these.

Report Highlights. The global market for pharmaceutical excipients will grow from nearly $ billion in to $ billion by with a compound annual growth rate (CAGR) of % for the period of The pharmaceutical excipients market report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of.

Overall sales in the global excipients market were worth $ billion inand increased to an estimated $ billion in Byit is projected to increase to $ billion, for a 5-year compound annual growth rate (CAGR) of %. Demand for pharmaceutical excipients in the US is projected to rise percent per year to $ billion in In volume terms, demand is expected to grow percent annually to million pounds over the same period.

The pharmaceutical excipients market was valued at USD Billion in and is expected to reach USD Billion byat a CAGR of .

Pharmaceutical excipients market worth 7 356 2 million
Rated 4/5 based on 48 review